Paul Welfordsson, Anna-Karin Danielsson, Caroline Björck, Bartosz Grzymala-Lubanski, Matthias Lidin, Ida Haugen Löfman, Sara Wallhed Finn
Mixed messages? Exposure to reports about alcohol's suggested cardiovascular effects and hazardous alcohol use: a cross-sectional study of patients in cardiology care
BMC public health
background objectives sarcopenic obesity clinical condition coexisting obesity sarcopenia associated high risk functional impairment reduced quality life increased mortality decline agerelated free testosterone ft levels reported associated decreased muscle mass muscle strength increased fat mass however association low ft levels risk sarcopenic obesity well studied study aimed investigate direct association low ft levels sarcopenic obesity materials methods crosssectional study used data 982 communitydwelling men aged 7084 years korean frailty aging cohort study sarcopenia defined according criteria asian group sarcopenia awgs 2019 obesity defined body fat mass 283 participants met sarcopenia obesity criteria defined sarcopenic obesity low ft levels defined ft levels 1735 pmoll according endocrine society clinical practice guidelines results prevalence sarcopenia obesity sarcopenic obesity significantly higher lowft group normalft group low ft levels significantly associated higher risk obesity odds ratio 209 95 confidence interval ci 111392 sarcopenia 257 95 ci 108610 sarcopenic obesity 366 95 ci 158847 compared healthy control group risk low appendicular skeletal muscle mass index asmi 178 95 ci 104302 high fat mass 192 95 ci 112331 significantly higher lowft group normalft group conclusions study showed low ft levels associated higher risk sarcopenic obesity low ft levels mainly related body composition parameters low asmi high fat mass